NCT07121972
Mirai-MRI: Validation of AI Models for Breast Cancer Risk
Recruiting
NAAges 40–89InterventionalScreeningUniversity of California, San FranciscoInvestigator-initiated
~400 participants
Updated 2025-11-06 on ClinicalTrials.gov
What's tested:Magnetic resonance imaging (MRI)Artificial Intelligence (AI)
At a glance
Recruiting sites
2 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Cancer detection rate (CDR)
Measured over Up to 1 year
Conditions
Where it's being run
4 sites across 3 statesCalifornia2
Illinois1
Massachusetts1
Study leadership
- Maggie Chung, MD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Cancer detection rate (CDR)Up to 1 year
The CDR is defined as the number of breast cancers identified per 1,000 magnetic resonance imaging (MRI) screening examinations performed 1 year following supplemental screening MRI.